Lyme Neuroborreliosis
Information
- Disease name
- Lyme Neuroborreliosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00037479 | Completed | Phase 2 | Brain Imaging and Retreatment Study of Persistent Lyme Disease | December 1999 | |
| NCT00138801 | Completed | Phase 3 | Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis | March 2004 | December 2008 |
| NCT01635530 | Completed | Phase 4 | Study of Lyme Neuroborreliosis | August 2012 | December 31, 2018 |
| NCT04577053 | Terminated | N/A | PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics | October 7, 2020 | September 28, 2021 |
| NCT03820999 | Unknown status | N/A | An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay | February 2019 | April 1, 2021 |
- MedGen concept unique identifier (MedGen Concept name)
- C0752235
- MedGen unique identifier (MedGen Concept name)
- 199846
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020852